A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Recent research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some ...

Shares of Mustang Bio MBIO skyrocketed 180.7% on Monday after the company announced that the FDA granted Orphan Drug ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

Targeted cancer drugs known as CDK4/6 inhibitors have improved outcomes for patients with advanced or metastatic HR+/HER2- ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

3D spheroids that are able to mimic the microenvironment of tumors effectively have emerged as significant structures in cancer biology and drug development. This study aims to help cancer researchers ...

Multidrug resistance (MDR) is one of the main causes of the failure in cancer chemotherapy. To address this challenge, this work develops a tumor-triggered nanomedicine (HA-MSDOX-KLA; comprised of a ...

These models can shed light on the fundamental biological processes behind milk production, tissue regeneration and the early ...

Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for ...